A combined effect of immune checkpoint inhibitors and a CD40 agonistic antibody in a pancreatic cancer mouse model

被引：0
|
作者：
Ichikawa, Juri [1 ]
Kawano, Kuniyuki [1 ,2 ]
Kato, Shingo [1 ,3 ]
Kurotaki, Daisuke [1 ,4 ]
Kuroishikawa, Ryo [1 ]
Kawase, Wataru [1 ,5 ]
Yoshida, Haruka [1 ]
Hiroshima, Yukihiko [5 ]
Endo, Itaru [6 ]
Maeda, Shin [2 ]
Nakajima, Atsushi [3 ]
Tamura, Tomohiko [1 ]
机构：
[1] Yokohama City Univ, Dept Immunol, Yokohama, Kanagawa, Japan
[2] Yokohama City Univ, Dept Gastroenterol, Yokohama, Kanagawa, Japan
[3] Yokohama City Univ, Dept Gastroenterol & Hepatol, Yokohama, Kanagawa, Japan
[4] Kumamoto Univ, Lab Chromatin Org Immune Cell Dev, Kumamoto, Japan
[5] Kanagawa Canc Ctr, Res Inst, Ctr Canc Genome Med, Yokohama, Kanagawa, Japan
[6] Yokohama City Univ, Dept Gastrol Surg, Yokohama, Kanagawa, Japan
来源：
CANCER SCIENCE | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
J-2009
引用
收藏
页码：763 / 763
页数：1
相关论文
共 50 条
  • [21] Immune checkpoint inhibitors combined with chemotherapy for the treatment of advanced pancreatic cancer patients
    Ma, Junxun
    Sun, Danyang
    Wang, Jinliang
    Han, Chun
    Qian, Yuanyu
    Chen, Guangying
    Li, Xiaoyan
    Zhang, Juan
    Cui, Pengfei
    Du, Wushuang
    Wu, Zhaozhen
    Chen, Shixue
    Zheng, Xuan
    Yue, Zhichao
    Song, Jia
    Gao, Chan
    Cai, Shangli
    Hu, Yi
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (03) : 365 - 372
  • [22] Immune checkpoint inhibitors combined with chemotherapy for the treatment of advanced pancreatic cancer patients
    Junxun Ma
    Danyang Sun
    Jinliang Wang
    Chun Han
    Yuanyu Qian
    Guangying Chen
    Xiaoyan Li
    Juan Zhang
    Pengfei Cui
    Wushuang Du
    Zhaozhen Wu
    Shixue Chen
    Xuan Zheng
    Zhichao Yue
    Jia Song
    Chan Gao
    Shangli Cai
    Yi Hu
    Cancer Immunology, Immunotherapy, 2020, 69 : 365 - 372
  • [23] Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic model
    Narayanan, Jayanth S. Shankara
    Hayashi, Tomoko
    Erdem, Suna
    McArdle, Sara
    Tiriac, Herve
    Ray, Partha
    Pu, Minya
    Mikulski, Zbigniew
    Miller, Aaron
    Messer, Karen
    Carson, Dennis
    Schoenberger, Stephen
    White, Rebekah R.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (01)
  • [24] Rationale and clinical development of CD40 agonistic antibodies for cancer immunotherapy
    Smith, Karin Enell
    Deronic, Adnan
    Hagerbrand, Karin
    Norlen, Per
    Ellmark, Peter
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (12) : 1635 - 1646
  • [25] APX005M is a potent CD40 agonistic antibody capable of stimulating both innate and adaptive immune responses against cancer
    Bjorck, Pia
    Filbert, Erin
    Trifan, Ovid
    Yang, Xiaodong
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [26] Uncovering the Potential of CD40 Agonism to Enhance Immune Checkpoint Blockade
    Wu, Richard C.
    Luke, Jason J.
    CLINICAL CANCER RESEARCH, 2024, 30 (01) : 9 - 11
  • [27] Ex vivo functional characterization and in vivo efficacy validation of human CD40 agonistic antibodies in the human CD40 knock-in model (CD40 HuGEMM)
    He, Daniel Xianfei
    Zheng, Lei
    Sun, Ruilin
    An, Annie Xiaoyu
    Fei, Jian
    Li, Henry Qixiang
    Ouyang, Davy Xuesong
    CANCER RESEARCH, 2019, 79 (13)
  • [28] Overcoming the resistance of pancreatic cancer to immune checkpoint inhibitors
    Skelton, Richard A.
    Javed, Ammar
    Zheng, Lei
    He, Jin
    JOURNAL OF SURGICAL ONCOLOGY, 2017, 116 (01) : 55 - 62
  • [29] Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma
    Luuk van Hooren
    Alessandra Vaccaro
    Mohanraj Ramachandran
    Konstantinos Vazaios
    Sylwia Libard
    Tiarne van de Walle
    Maria Georganaki
    Hua Huang
    Ilkka Pietilä
    Joey Lau
    Maria H. Ulvmar
    Mikael C. I. Karlsson
    Maria Zetterling
    Sara M. Mangsbo
    Asgeir S. Jakola
    Thomas Olsson Bontell
    Anja Smits
    Magnus Essand
    Anna Dimberg
    Nature Communications, 12
  • [30] Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma
    van Hooren, Luuk
    Vaccaro, Alessandra
    Ramachandran, Mohanraj
    Vazaios, Konstantinos
    Libard, Sylwia
    van de Walle, Tiarne
    Georganaki, Maria
    Huang, Hua
    Pietilae, Ilkka
    Lau, Joey
    Ulvmar, Maria H.
    Karlsson, Mikael C. I.
    Zetterling, Maria
    Mangsbo, Sara M.
    Jakola, Asgeir S.
    Bontell, Thomas Olsson
    Smits, Anja
    Essand, Magnus
    Dimberg, Anna
    NATURE COMMUNICATIONS, 2021, 12 (01)
12345